Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0750
0.00 (0.00%)
Aug 27, 2025, 1:00 PM AEST
Firebrick Pharma Market Cap
Firebrick Pharma has a market cap or net worth of 17.05 million as of August 29, 2025. Its market cap has increased by 55.88% in one year.
Market Cap
17.05M
Enterprise Value
16.14M
Revenue
524.69K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since January 28, 2022, Firebrick Pharma's market cap has decreased from 89.49M to 17.05M, a decrease of -80.95%. That is a compound annual growth rate of -37.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 17.05M | 30.88% |
| Dec 31, 2024 | 13.03M | 46.33% |
| Dec 29, 2023 | 8.90M | -77.12% |
| Dec 29, 2022 | 38.92M | -56.51% |
| Jan 28, 2022 | 89.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 102.99B |
| Pro Medicus | 31.35B |
| Cochlear | 19.63B |
| Sonic Healthcare | 11.81B |
| Ramsay Health Care | 7.83B |
| Telix Pharmaceuticals | 5.06B |
| Ansell | 5.00B |
| Mesoblast | 3.10B |